Abstract
Frequency of high-risk hormone receptor-positive breast cancer patients was much higher in Japanese breast cancer patients with germline BRCA1/2 mutations than in sporadic breast cancer patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have